Results 71 to 80 of about 86,733,728 (163)

Mitral Valve Transcatheter Edge-to-Edge Repair: 1-Year Outcomes From the MiCLASP Study. [PDF]

open access: yes
BACKGROUND Mitral transcatheter edge-to-edge repair (M-TEER) is a guideline-recommended treatment option for patients with severe symptomatic mitral regurgitation (MR). Outcomes with the PASCAL system in a post-market setting have not been established.
Eitel, Ingo   +38 more
core   +2 more sources

Mitral Transcatheter Edge‐to‐Edge Repair in Younger Adults

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Younger patients aged ≤65 years who have significant comorbidities deemed unsuitable for surgery, transcatheter edge‐to‐edge repair (TEER) may serve as an alternative, although the long‐term outcomes remain uncertain.
Yuchao Guo   +15 more
doaj   +1 more source

Comprehensive Nursing Management of Anticoagulation and Heart Failure Surveillance in a Chinese Patient With Mirror‐Image Dextrocardia Post‐MitraClip Surgery: A First Case Report

open access: yesCatheterization and Cardiovascular Interventions, Volume 107, Issue 6, Page 1960-1963, May 1, 2026.
ABSTRACT Background Mitral regurgitation (MR) is the valent type of valvular heart disease, caused by primary leaflet lesions or annular dilatation secondary to left ventricular dysfunction. It can lead to a series of complications such as volume overload, exacerbated pulmonary congestion, and heart failure, significantly impacting patient prognosis ...
Juelian Li   +4 more
wiley   +1 more source

Multicenter Evaluation of an Edge-to-Edge Repair System in High-Risk Patients With Degenerative Mitral Regurgitation

open access: yesStructural Heart
Background: Transcatheter edge-to-edge repair (TEER) has become an effective alternative for treating degenerative mitral regurgitation (DMR) in patients at high surgical risk.
Kai Xu, MD, PhD   +29 more
doaj   +1 more source

Advances in transcatheter mitral and tricuspid therapies

open access: yesBMC Cardiovascular Disorders, 2020
Background While rheumatic mitral stenosis has been effectively treated percutaneously for more than 20 years, mitral and tricuspid regurgitation treatment appear as a contemporary unmet need.
Pavel Overtchouk   +5 more
doaj   +1 more source

Mission M-Possible: Mitral Transcatheter Edge-to-Edge Repair in Mitral Annular Calcification Using the Crab-Walk Technique. [PDF]

open access: yesStruct Heart
Background: Mitral annular calcification (MAC) complicates transcatheter interventions for degenerative mitral regurgitation (DMR), particularly with small mitral valve orifice areas (MVOAs). Case Summary: An 83-year-old woman with severe DMR, severe MAC,
Abdelmalek J   +6 more
europepmc   +2 more sources

Concomitant Transcatheter Edge‐to‐Edge Repair for Mitral and Tricuspid Regurgitation for Polyvalvular Disease

open access: yesCatheterization and Cardiovascular Interventions, Volume 107, Issue 6, Page 2098-2099, May 1, 2026.
ABSTRACT This patient is a 77‐year‐old male with non‐ischemic cardiomyopathy, severe tricuspid regurgitation, and moderate mitral regurgitation who underwent simultaneous transcatheter edge‐to‐edge repair of both mitral and tricuspid valves. Post‐procedure, the patient exhibited significant symptomatic improvement and reduced regurgitation severity ...
Omar Khan, Matthew Summers
wiley   +1 more source

Transcatheter Treatment Options for Functional Mitral Regurgitation: Which Device for Which Patients?

open access: yesInterventional Cardiology: Reviews, Research, Resources
Mitral regurgitation is the most common valvular disease in the developed world, with approximately 24.2 million people being affected worldwide and a higher prevalence in older age groups.
Stephanie K Tom   +7 more
doaj   +1 more source

Rationale and Design of the Türkiye Heart Failure (TURK‐HF) Registry

open access: yesClinical Cardiology, Volume 49, Issue 5, May 2026.
ABSTRACT Aims The Türkiye Heart Failure (TURK‐HF) registry aims to identify the sociodemographic and clinical characteristics, management strategies, and outcomes of patients with heart failure (HF) and to assess the implementation of evidence‐based HF therapies in Türkiye.
Umut Kocabas   +46 more
wiley   +1 more source

Safety and Efficacy of LockeT Suture Retention Device for Large‐Bore Venous Access Closure

open access: yesJournal of Cardiovascular Electrophysiology, Volume 37, Issue 5, Page 1015-1020, May 2026.
ABSTRACT Background Electrophysiology (EP) procedures increasingly require large‐bore venous access (LBVA), which is associated with a higher risk of vascular complications. While vascular closure devices (VCDs) are well established for arterial access, data on venous closure—particularly for LBVA—remain limited.
Pedro J. Diaz Delgado   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy